New targeted therapy shows promising early results in advanced pancreatic cancer

MedicalXpress | 七月 05, 2026

An investigational targeted therapy designed to block one of the most common genetic drivers of pancreatic cancer has shown promising early results when combined with standard first-line chemotherapy, according to research presented today at the ESMO Gastrointestinal Cancers Congress 2026.